As of November 2026 Galectin Therapeutics has a market cap of ยฃ0.25 Billion. This makes Galectin Therapeutics the world's 8218th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 9th, 2026 the market cap of Galectin Therapeutics was reported to be: